Fig. 1.
Schematic representation of the sites of action of glucose-lowering drug (bold characters) and modes of action. DPP-4 inhibitor, dipeptidyl peptidase-4 inhibitor. SGLT2 inhibitor, sodium glucose cotransporter-2 inhibitor.
Schematic representation of the sites of action of glucose-lowering drug (bold characters) and modes of action. DPP-4 inhibitor, dipeptidyl peptidase-4 inhibitor. SGLT2 inhibitor, sodium glucose cotransporter-2 inhibitor.
